☰

Cory L. Pelletier, Ph.D. - Publications

Affiliations: 
2010 Yale University, New Haven, CT 
Area:
Genetics
Tree Info Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Paranjape T, Heneghan H, Lindner R, Keane FK, Hoffman A, Hollestelle A, Dorairaj J, Geyda K, Pelletier C, Nallur S, Martens JW, Hooning MJ, Kerin M, Zelterman D, Zhu Y, et al. A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. The Lancet. Oncology. 12: 377-86. PMID 21435948 DOI: 10.1016/S1470-2045(11)70044-4  0.59
2011 Pelletier C, Speed WC, Paranjape T, Keane K, Blitzblau R, Hollestelle A, Safavi K, van den Ouweland A, Zelterman D, Slack FJ, Kidd KK, Weidhaas JB. Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk. Cell Cycle (Georgetown, Tex.). 10: 90-9. PMID 21191178 DOI: 10.4161/Cc.10.1.14359  0.572
2011 Hollestelle A, Pelletier C, Hooning M, Crepin E, Schutte M, Look M, Collee JM, Nieuwlaat A, Dorssers LC, Seynaeve C, Aulchenko YS, Martens JW, van den Ouweland AM, Weidhaas JB. Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families. Breast Cancer Research and Treatment. 128: 79-84. PMID 20676756 DOI: 10.1007/S10549-010-1080-Z  0.549
2011 Weidhaas J, Slack F, Miller N, Harris L, Tuck D, Zhu Y, Zelterman D, Kerin M, Paranjape T, Heneghan H, Lindner R, Keane F, Dorairaj J, Geyda K, Pelletier C, et al. Association between KRAS rs61764370 and triple-negative breast cancer-a false positive? - Authors' reply The Lancet Oncology. 12: 724. DOI: 10.1016/S1470-2045(11)70163-2  0.481
2010 Pelletier C, Weidhaas JB. MicroRNA binding site polymorphisms as biomarkers of cancer risk. Expert Review of Molecular Diagnostics. 10: 817-29. PMID 20843204 DOI: 10.1586/Erm.10.59  0.468
2010 Ratner E, Lu L, Boeke M, Barnett R, Nallur S, Chin LJ, Pelletier C, Blitzblau R, Tassi R, Paranjape T, Hui P, Godwin AK, Yu H, Risch H, Rutherford T, et al. A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Research. 70: 6509-15. PMID 20647319 DOI: 10.1158/0008-5472.Can-10-0689  0.516
2010 Paranjape TS, Heneghan H, Pelletier C, Hoffman A, Kerin MJ, Harris L, Zhu Y, Miller N, Zelterman D, Tuck D, Slack F, Weidhaas J. Abstract 3029: A KRAS microRNA binding site polymorphism as a novel biomarker of risk in triple negative breast cancer Cancer Research. 70: 3029-3029. DOI: 10.1158/1538-7445.Am10-3029  0.498
Show low-probability matches.